文献速递心肺康复

肺康复改善特发性肺纤维化患者运动耐量与生活质量:系统综述与荟萃分析

Clinical evidence for improving exercise tolerance and quality of life with pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
PubMed 文献 · Clin Rehabil · 2022-04-28

该系统综述与荟萃分析纳入11项随机对照试验共549例特发性肺纤维化患者,评估肺康复对比常规护理的疗效。结果显示肺康复可显著提高6分钟步行距离(平均差35.2米,95%CI 25.4–44.9米)并降低圣乔治呼吸问卷总分(平均差-9.11,95%CI -10.78至-7.43),证据质量中至低。

要点

  • 肺康复显著提高特发性肺纤维化患者6分钟步行距离,平均差35.2米(95%CI 25.4–44.9米)。
  • 肺康复显著降低圣乔治呼吸问卷总分,平均差-9.11(95%CI -10.78至-7.43)。
  • 证据质量中至低,仍需大样本多中心随机对照试验验证疗效与安全性。

核心结论

  • 肺康复可能显著改善特发性肺纤维化患者的运动耐量与生活质量,但证据质量低至中等。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、Cochrane Library、Embase、Web of Science、中国生物医学文献数据库、中国知网、万方数据库和维普数据库,纳入比较肺康复与常规护理的随机对照试验,共11项试验549例参与者。

主要发现

  • 与常规护理相比,肺康复显著增加6分钟步行距离(平均差35.2米,95%CI 25.4–44.9米;10项试验447例;中等质量证据)。
  • 肺康复显著降低圣乔治呼吸问卷总分(平均差-9.11,95%CI -10.78至-7.43;6项试验303例;中等质量证据)。
  • 肺康复显著降低改良医学研究委员会评分(平均差-0.76,95%CI -1.25至-0.27;3项试验196例;低质量证据)。
  • 肺康复显著改善用力肺活量占预计值百分比(平均差4.88,95%CI 2.67–7.10;4项试验214例;中等质量证据)。
  • 肺康复显著改善一氧化碳弥散量(平均差4.71,95%CI 0.96–8.46;6项试验358例;低质量证据)。

临床怎么用

  • 对特发性肺纤维化患者可考虑采用肺康复以改善运动耐量和生活质量。
  • 临床决策时应考虑现有证据质量中至低,需结合患者具体情况个体化实施。

局限性

  • 纳入研究的证据质量低至中等。
  • 需要大样本、多中心、随机对照试验验证肺康复的疗效与安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the efficacy and safety of pulmonary rehabilitation for exercise tolerance and quality of life improvement in idiopathic pulmonary fibrosis. METHODS: We searched PubMed, Cochrane Library, Embase, Web of Science, Chinese Biomedical Literature Database, China National Knowledge Infrastructure, Wanfang Database, and Chongqing VIP for randomized controlled trials that compared pulmonary rehabilitation with usual care for idiopathic pulmonary fibrosis. The risk of bias and certainty of evidence were assessed using Cochrane Collaboration's Risk of Bias tool and the Grading of Recommendations, Assessment, Development and Evaluation criteria. RESULTS: Eleven trials in total with 549 participants. Compared with usual care, pulmonary rehabilitation significantly increased 6-minute walking distance (mean difference: 35.2m, 95% confidence intervals: 25.4m-44.9m; ten trials; 447 participants; moderate), decreased the St George's Respiratory Questionnaire total scores (mean difference: -9.11, 95% confidence intervals: -10.78 to -7.43; six trials; 303 participants; moderate), and reduced the modified Medical Research Council scores were lower (mean difference: -0.76, 95% confidence intervals: -1.25 to -0.27; three trials; 196 participants; low). Improvements were noted in forced vital capacity percent-predicted (mean difference: 4.88, 95% confidence intervals: 2.67 to 7.10; four trials; 214 participants; moderate) and diffusing capacity for carbon monoxide (mean difference: 4.71, 95% confidence intervals: 0.96 to 8.46; six trials; 358 participants; low). CONCLUSIONS: Pulmonary rehabilitation may significantly improve exercise tolerance and quality of life in idiopathic pulmonary fibrosis patients, but the quality of evidence was low to moderate. Large sample, multicenter, randomized controlled trials are needed to verify the efficacy and safety of pulmonary rehabilitation.

来源:Clin Rehabil,查看原文。版权归原作者所有。

引用

  1. Lei S, Li X, Xie Y, et al. Clinical evidence for improving exercise tolerance and quality of life with pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis: A systematic review and meta-analysis. Clin Rehabil. 2022. PMID: 35481421. doi:10.1177/02692155221095481

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。